Beloqui O - Search Results

1

Splenic embolization prior to myelosuppressive treatment in hepatocarcinoma and active chronic hepatitis.

Bilbao JI, Sangro B, Longo JM, Zozaya JM, Fernández-Virgós A, Aquerreta JD, Beloqui O, Prieto J. Bilbao JI, et al. Among authors: beloqui o. Eur J Radiol. 1992 Oct;15(3):211-4. doi: 10.1016/0720-048x(92)90109-m. Eur J Radiol. 1992. PMID: 1337037

2

Partial splenic embolization for the treatment of hypersplenism in cirrhosis.

Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, Ruiz J, Zozaya JM, Quiroga J, Prieto J. Sangro B, et al. Among authors: beloqui o. Hepatology. 1993 Aug;18(2):309-14. Hepatology. 1993. PMID: 8340060

3

Hepatitis B and C viral infections in patients with hepatocellular carcinoma.

Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J. Ruiz J, et al. Among authors: beloqui o. Hepatology. 1992 Sep;16(3):637-41. doi: 10.1002/hep.1840160305. Hepatology. 1992. PMID: 1380480

4

Percutaneous transgastric cystoduodenostomy in the treatment of a pancreatic pseudocyst: a new approach.

Bilbao JI, Alejandre PL, Longo JM, de Villa V, Larrea JA, Beloqui O, Lecumberri FJ. Bilbao JI, et al. Among authors: beloqui o. Cardiovasc Intervent Radiol. 1995 Nov-Dec;18(6):422-5. doi: 10.1007/BF00338315. Cardiovasc Intervent Radiol. 1995. PMID: 8591634

5

Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome.

Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, Sangro B. Prieto J, et al. Among authors: beloqui o. Hepatology. 1996 Feb;23(2):199-204. doi: 10.1002/hep.510230201. Hepatology. 1996. PMID: 8591841

6

Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution.

Sangro B, Herráiz M, Martínez-González MA, Bilbao I, Herrero I, Beloqui O, Betés M, de-la-Peña A, Cienfuegos JA, Quiroga J, Prieto J. Sangro B, et al. Among authors: beloqui o. Surgery. 1998 Sep;124(3):575-83. Surgery. 1998. PMID: 9736912

7

N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.

Beloqui O, Prieto J, Suárez M, Gil B, Qian CH, García N, Civeira MP. Beloqui O, et al. J Interferon Res. 1993 Aug;13(4):279-82. doi: 10.1089/jir.1993.13.279. J Interferon Res. 1993. PMID: 8228388

8

Efficacy and toxicity of intra-arterial cisplatin and etoposide for advanced hepatocellular carcinoma.

Sangro B, Rios R, Bilbao I, Beloqui O, Herrero JI, Quiroga J, Prieto J. Sangro B, et al. Among authors: beloqui o. Oncology. 2002;62(4):293-8. doi: 10.1159/000065059. Oncology. 2002. PMID: 12138235

9

Superoxide dismutase in patients with chronic hepatitis C virus infection.

Larrea E, Beloqui O, Muñoz-Navas MA, Civeira MP, Prieto J. Larrea E, et al. Among authors: beloqui o. Free Radic Biol Med. 1998 May;24(7-8):1235-41. doi: 10.1016/s0891-5849(97)00437-1. Free Radic Biol Med. 1998. PMID: 9626579 Free article.

10

[Extrahepatic manifestations of hepatitis C virus].

Yuste JR, Beloqui O, Garcia N, Prieto J. Yuste JR, et al. Among authors: beloqui o. An Med Interna. 1995 Dec;12(12):609-16. An Med Interna. 1995. PMID: 8679807 Review. Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters